Cardiol Therapeutics Inc. Adjustments For Share-based Payments
Cardiol Therapeutics Inc. (CRDL) reported Adjustments For Share-based Payments of CAD 10.70 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-03-31
| Period end | Adjustments For Share-based Payments 12 month |
|---|---|
| 2025-12-31 | 10.70M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 14.28M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 4.16M CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 5.01M CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 8.50M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 2.77M CAD 20-F · filed 2023-03-29 |